Drug Shortage Report for SCOPOLAMINE HYDROBROMIDE INJECTION

Last updated on 2024-02-20 History
Report ID 218664
Drug Identification Number 02242810
Brand name SCOPOLAMINE HYDROBROMIDE INJECTION
Common or Proper name Scopolamine Hydrobromide Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) SCOPOLAMINE HYDROBROMIDE
Strength(s) 0.4MG
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 1 mL vial / fiole
ATC code N05CM
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-02-13
Actual start date 2024-02-13
Estimated end date
Actual end date 2024-02-19
Shortage status Resolved
Updated date 2024-02-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2024-02-20 English Compare
v10 2024-02-16 French Compare
v9 2024-02-16 English Compare
v8 2024-02-16 English Compare
v7 2024-02-14 English Compare
v6 2024-02-13 French Compare
v5 2024-02-13 English Compare
v4 2024-02-13 French Compare
v3 2024-02-13 English Compare
v2 2024-02-06 French Compare
v1 2024-02-06 English Compare

Showing 1 to 11 of 11